Health  Vol.9 No.4 , April 2017
Preventive Effect of Lactococcus lactis subsp. lactis JCM 5805 Yogurt Intake on Influenza Infection among Schoolchildren
Objective: A community-based intervention study was conducted to examine the effect of consumption of JCM 5805 yogurt on influenza incidence rates and the cumulative incidence rates among schoolchildren in Iwate Prefecture, Japan. Methods: Schoolchildren and their parents in Shizukuishi town were told of the purpose, frequency and duration of JCM 5805 yogurt administration. The number of elementary schoolchildren in Shizukuishi town was 780 while that of junior high school students in Shizukuishi town numbered 475. The number of elementary schoolchildren in neighboring town A was 208 and that of junior high school students in town A was 121. JCM 5805 yogurt was delivered three times a week to all elementary schools and junior high schools in Shizukuishi town from January 16 through March 18, 2015. The incidence rate was calculated every week as the maximum case number divided by the number of schoolchildren in each school. The cumulative incidence rate was calculated as the total case number during the period when JCM 5805 yogurt was delivered divided by the number of schoolchildren in each school. Results: JCM 5805 yogurt intake was associated with a two-thirds reduction in influenza incidence rates in Shizukuishi town schoolchildren compared with those of town A. Furthermore, the cumulative incidence rates of the elementary school and combined data from the elementary school and junior high school were significantly lower than those of neighbor town A. Conclusion: JCM 5805 yogurt intake reduced both the incidence rates and cumulative incidence rates of influenza.
Cite this paper: Sakata, K. , Sasaki, Y. , Jounai, K. , Fujii, T. and Fujiwara, D. (2017) Preventive Effect of Lactococcus lactis subsp. lactis JCM 5805 Yogurt Intake on Influenza Infection among Schoolchildren. Health, 9, 756-762. doi: 10.4236/health.2017.94054.

[1]   Fontana, L., Bermudez-Brito, M., Plaza-Diaz, J., Muñoz-Quezada, S. and Gil, A. (2013) Sources, Isolation, Characterisation and Evaluation of Probiotics. British Journal of Nutrition, 109, s35-s50.

[2]   Jounai, K., Ikado, K., Sugimura, T., Ano, Y., Braun, J. and Fujiwara, D. (2012) Spherical Lactic Acid Bacteria Activate Plasmacytoid Dendritic Cells Immunomodulatory Function via TLR9-Dependent Crosstalk with Myeloid Dendritic Cells. PLOS ONE, 7, e32588.

[3]   Jounai, K., Sugimura, T., Ohshio, K. and Fujiwara, D. (2015) Oral Administration of Lactococcus Lactis Subsp. Lactis JCM 5805 Enhances Lung Immune Response Resulting in Protection from Murine Parainfluenza Virus Infection. PLOS ONE, 10, e0119055.

[4]   Sugimura, T., Takahashi, H., Jounai, K., Ohshio, K., Kanayama, M., Tazumi, K., et al. (2015) Effects of Oral Intake of Plasmacytoid Dendritic Cells-Stimulative Lactic Acid Bacterial Strain on Pathogenesis of Influenza-Like Illness and Immunological Response to Influenza Virus. British Journal of Nutrition, 114, 727-733.

[5]   Suzuki, H., Ohshio, K. andFujiwara, D. (2016) Lactococcus Lactis subsp. Lactis JCM 5805 Activates Natural Killer Cells via Dendritic Cells. Bioscience, Biotechnology, and Biochemistry, 80, 798-800.

[6]   Sugimura, T., Jounai, K., Ohshio, K., Tanaka, T., Suwa, M. and Fujiwara, D. (2013) Immunomodulatory Effect of Lactococcus Lactis JCM 5805 on Human Plasmacytoid Dendritic Cells. Clinical Immunology, 149, 509-518.

[7]   Lenschow, D.J., Lai, C., Frias-Staheli, N., Giannakopoulos, N.V., Lutz, A., Wolf, T., et al. (2007) IFN-Stimulated Gene 15 Functions as a Critical Antiviral Molecule against Influenza, Herpes, and Sindbis Viruses. Proceedings of the National Academy of Sciences of the United States of America, 104, 1371-1376.

[8]   National Institute of Infectious Diseases. (2017) Antiviral Resistance Surveillance in Japan.

[9]   Tashiro, M., McKimm-Breschkin, J.L., Saito, T., Klimov, A., Macken, C., Zambon, M., et al. (2009) Surveillance for Neuraminidase-Inhibitor-Resistant Influenza Viruses in Japan, 1996-2007. Antiviral Therapy, 14, 751-761.